Inventor
Arthur A. Vandenbark
Inventor
Portland, OR, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C12NMicroorganisms or enzymes6%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
A61BDiagnosis4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,689,446Recombinant CD74 polypeptides202010,525,101Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor202010,316,075Recombinant polypeptides comprising MHC class II a1 domains20199,926,360'Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells'20189,492,536'Compositions and methods using recombinant MHC molecules for the treatment of stroke'20169,359,425'Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction'20169,260,506'Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)'20169,243,051'Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells'20169,050,279'Compositions and methods using recombinant MHC molecules for the treatment of stroke'20158,895,018'Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction'20148,685,404'Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction'20148,491,913'Compositions and methods using recombinant MHC molecules for the treatment of stroke'20138,435,507'Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer'20138,377,447'Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells'20138,053,197'Methods for detecting and treating autoimmune disorders'20117,732,140'Method for direct electrical detection of molecules and molecule-molecule interactions'20107,462,486'Methods of selecting T cell receptor V peptides for therapeutic use'20087,265,218'Recombinant MHC molecules useful for manipulation of antigen-specific T-cells'20077,214,528'Device for direct electrical detection of molecules and molecule-molecule interactions'20076,815,171'Recombinant MHC molecules useful for manipulation of antigen-specific T-cells'20046,566,082'T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions'20036,270,772'Recombinant MHC molecules useful for manipulation of antigen-specific T-cells'20015,776,459'TCR V beta 5 peptides'19985,759,546'Treatment of CD4 T-cell mediated conditions'19985,614,192'T cell receptor peptides as therapeutics for immune-related disease'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2020Based in Portland, OR, US· patent location history
2004–2020Patents assigned to UNIV OREGON HEALTH & SCIENCE (18)· patent assignee history
2008–2016Patents assigned to US DEPT VETERANS AFFAIRS (11)· patent assignee history
2013–2016Patents assigned to VANDENBARK ARTHUR A (5)· patent assignee history
2013–2016Patents assigned to BURROWS GREGORY G (3)· patent assignee history
2018–2020Patents assigned to US GOV VETERANS AFFAIRS (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV OREGON HEALTH & SCIENCE | 18 | 2004–2020 |
| US DEPT VETERANS AFFAIRS | 11 | 2008–2016 |
| VANDENBARK ARTHUR Aself | 5 | 2013–2016 |
| BURROWS GREGORY G | 3 | 2013–2016 |
| US GOV VETERANS AFFAIRS | 3 | 2018–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Portland, OR, US | 25 | 1997–2020 |